in the news

Recent Rosacea Blog Posts

Galderma announces approval of Soolantra

Galderma has announced today that their 1% Ivermectin cream in development for rosacea as CD5024 has been approved and is now known as Soolantra. Soolantra appears to be going to be promoted as a treatment that is quicker and more effective than Metrogel 0.75%. Soolantra has been in development as CD5024 for many years. The […]

Continue Reading

Mirvaso features in Sky TV’s My Naked Secret

Rosacea Forum user rosaceaclearwannabe has posted about a recent episode of My Naked Secret that features a participant who was treated with Mirvaso. The show follows Anna who suffers from the red face of rosacea. She is followed as she becomes one of the first people in Europe to try being treated with Mirvaso. The […]

Continue Reading

News today that the former owners of the patent covering the product Mirvaso have sued Galderma over a contract dispute. The 5 former owners of Sansrosa say that a contract error will cost them $20m. Sansrosa, who was then owned by Collagenex was sold to Galderma in 2008. Galderma asserts a group of patents protect […]

Continue Reading

Mirvaso launches as ONRELTEA in Canada

Galderma has reached into its bag of trademarks and announced that Mirvaso will be known as ONRELTEA in Canada. Red Faced? Rosacea Sufferers Now Have a New Option Proven to Reduce Facial Redness Health Canada Approves The First and Only Topical Treatment Indicated for the Persistent Facial Erythema of Rosacea THORNHILL, ON, May 21, 2014 […]

Continue Reading

Nestle now calling the shots at Galderma

Galderma, the biggest pharmaceutical company of interest to rosacea sufferers has had a subtle, but potentially important change in ownership. Galderma was created in 1981 as a joint venture between L’Oréal and Nestlé and is of course known for their prescription products like Metrogel, Oracea and Mirvaso as well as skincare products like Cetaphil. So […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.